S

Surgalign Holdings Inc
F:RT2

Watchlist Manager
Surgalign Holdings Inc
F:RT2
Watchlist
Price: 3.03 EUR -2.73% Market Closed
Market Cap: €20.1m

Wall Street
Price Targets

RT2 Price Targets Summary
Surgalign Holdings Inc

There are no price targets for RT2.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Surgalign Holdings Inc Competitors:
Price Targets
XLO
Xilio Therapeutics Inc
243% Upside
ARGX
argenx SE
47% Upside
MRNA
Moderna Inc
-11% Downside

Revenue
Forecast

-14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 8 years the compound annual growth rate for Surgalign Holdings Inc's revenue is -14%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Surgalign Holdings Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RT2's stock price target?
Not Available

RT2 doesn't have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett